Navigating drug development with human multi-omics data and AI

However, there has never been a better time to fix this: biomedical data on human genetics, -omics, and clinical outcomes is becoming available for millions of real-world individuals. Pheiron’s platform integrates data from the world’s largest human biobanks, and combines human genetics with multi-modal AI, to accurately resolve disease pathology, and identify causal links between mechanisms, pathology and patient populations. In this talk, Thore explains how Pheiron's human-level insights help identifying targets and de-risk translation.

Speaker
Thore Bürgel, PhD
Co-founder and CEO Pheiron

More information and the sign-up link can be found here.